T1	Intervention 0 47	Low-dose oral etoposide-based induction regimen
T2	Intervention 164 182	low-dose etoposide
T3	Intervention 338 382	epipodophyllotoxins during frontline therapy
T4	Intervention 452 541	etoposide (50 mg/m(2) per day) administered orally as a single agent once or twice daily.
T5	Intervention 580 626	dexamethasone, vincristine, and L-asparaginase
T6	Intervention 628 637	Etoposide
T7	Intervention 669 787	Two courses of consolidation therapy were followed by continuation therapy or hematopoietic stem cell transplantation.
T8	Intervention 1230 1268	low-dose etoposide administered orally
